We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · April 17, 2021

Omalizumab Appears to Decrease Bronchoalveolar Lavage Matrix Metalloproteinases in Severe Allergic Asthma

The Journal of Asthma : Official Journal of the Association for the Care of Asthma

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Journal of Asthma : Official Journal of the Association for the Care of Asthma
Effect of Omalizumab on Bronchoalveolar Lavage Matrix Metalloproteinases in Severe Allergic Asthma
J Asthma 2021 Mar 25;[EPub Ahead of Print], W Zastrzeżyńska, S Bazan-Socha, M Przybyszowski, A Gawlewicz-Mroczka, B Jakieła, H Plutecka, L Zaręba, J Musiał, K Okoń, K Sładek, J Soja

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading